Abraham Ceesay - Net Worth and Insider Trading

Abraham Ceesay Net Worth

The estimated net worth of Abraham Ceesay is at least $25 Million dollars as of 2026-09-11. Abraham Ceesay is the CEO of Rapport Therapeutics Inc and owns about 561,435 shares of Rapport Therapeutics Inc (RAPP) stock worth over $24 Million. Abraham Ceesay is the Director of Pacira BioSciences Inc and owns about 9,039 shares of Pacira BioSciences Inc (PCRX) stock worth over $227,421. Abraham Ceesay is also the President of Cerevel Therapeutics Holdings Inc and owns about 0 shares of Cerevel Therapeutics Holdings Inc (CERE) stock worth over $0. Details can be seen in Abraham Ceesay's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Abraham Ceesay has not made any transactions after 2026-09-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Abraham Ceesay

To

Abraham Ceesay Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Abraham Ceesay owns 5 companies in total, including scPharmaceuticals Inc (SCPH) , Cerevel Therapeutics Holdings Inc (CERE) , and Pacira BioSciences Inc (PCRX) among others .

Click here to see the complete history of Abraham Ceesay’s form 4 insider trades.

Insider Ownership Summary of Abraham Ceesay

Ticker Company Transaction Date Type of Owner
SCPH scPharmaceuticals Inc 2017-11-16 Chief Operating Officer
CERE Cerevel Therapeutics Holdings Inc 2022-09-08 President
PCRX Pacira BioSciences Inc 2025-09-04 director
LIMIT LIMIT 2026-09-08 director & Chief Executive Officer
LIMIT LIMIT 2025-05-20 director

Abraham Ceesay Latest Holdings Summary

Abraham Ceesay currently owns a total of 3 stocks. Among these stocks, Abraham Ceesay owns 561,435 shares of Rapport Therapeutics Inc (RAPP) as of September 8, 2026, with a value of $24 Million and a weighting of 99.08%. Abraham Ceesay owns 9,039 shares of Pacira BioSciences Inc (PCRX) as of September 4, 2025, with a value of $227,421 and a weighting of 0.92%. Abraham Ceesay also owns 0 shares of Cerevel Therapeutics Holdings Inc (CERE) as of September 8, 2022, with a value of $0 and a weighting of 0%.

Latest Holdings of Abraham Ceesay

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RAPP Rapport Therapeutics Inc 2026-09-08 561,435 43.46 24,399,965
PCRX Pacira BioSciences Inc 2025-09-04 9,039 25.16 227,421
CERE Cerevel Therapeutics Holdings Inc 2022-09-08 0 44.96 0

Holding Weightings of Abraham Ceesay


Abraham Ceesay Form 4 Trading Tracker

According to the SEC Form 4 filings, Abraham Ceesay has made a total of 12 transactions in Rapport Therapeutics Inc (RAPP) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in Rapport Therapeutics Inc is the sale of 8,210 shares on September 8, 2026, which brought Abraham Ceesay around $374,458.

According to the SEC Form 4 filings, Abraham Ceesay has made a total of 1 transactions in Pacira BioSciences Inc (PCRX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Pacira BioSciences Inc is the sale of 2,354 shares on September 4, 2025, which brought Abraham Ceesay around $64,005.

According to the SEC Form 4 filings, Abraham Ceesay has made a total of 4 transactions in Cerevel Therapeutics Holdings Inc (CERE) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Cerevel Therapeutics Holdings Inc is the sale of 19,210 shares on September 8, 2022, which brought Abraham Ceesay around $624,325.

Insider Trading History of Abraham Ceesay

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Abraham Ceesay Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Get the full picture on these stocks
See GF Score, valuation, financials, and warning signs for every stock Abraham Ceesay owns.
View RAPP Analysis

Abraham Ceesay Ownership Network

Ownership Network List of Abraham Ceesay

No Data

Ownership Network Relation of Abraham Ceesay

Insider Network Chart


Abraham Ceesay Owned Company Details

What does scPharmaceuticals Inc do?

Who are the key executives at scPharmaceuticals Inc?

Abraham Ceesay is the Chief Operating Officer of scPharmaceuticals Inc. Other key executives at scPharmaceuticals Inc include 10 percent owner Orbimed Advisors Llc , 10 percent owner 5am Partners Iv, Llc , and director & President and CEO John H Tucker .

scPharmaceuticals Inc (SCPH) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of scPharmaceuticals Inc (SCPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of scPharmaceuticals Inc (SCPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

scPharmaceuticals Inc (SCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

scPharmaceuticals Inc Insider Transactions

No Available Data

Abraham Ceesay Mailing Address

Above is the net worth, insider trading, and ownership report for Abraham Ceesay. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Abraham Ceesay's mailing address is: Burlington Ma 01830.